Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1897 1
1911 1
1913 1
1917 2
1921 2
1932 1
1935 1
1936 2
1945 2
1946 4
1947 5
1948 4
1949 1
1951 1
1952 2
1953 1
1954 1
1955 2
1956 3
1957 3
1958 1
1959 4
1960 4
1961 2
1962 3
1963 1
1964 1
1966 1
1967 1
1968 1
1969 3
1970 2
1971 5
1972 3
1973 4
1974 1
1975 4
1976 6
1977 6
1978 11
1979 17
1980 15
1981 14
1982 12
1983 22
1984 17
1985 25
1986 18
1987 22
1988 24
1989 17
1990 13
1991 22
1992 22
1993 21
1994 26
1995 32
1996 35
1997 27
1998 33
1999 30
2000 42
2001 26
2002 25
2003 25
2004 26
2005 32
2006 35
2007 30
2008 26
2009 30
2010 34
2011 35
2012 39
2013 51
2014 60
2015 62
2016 63
2017 54
2018 56
2019 52
2020 57
2021 56
2022 55
2023 53
2024 44
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,544 results

Results by year

Filters applied: . Clear all
Page 1
Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review.
Stretton B, Kovoor J, Bacchi S, Chang S, Ngoi B, Murray T, Bristow TC, Heng J, Gupta A, Ovenden C, Maddern G, Thompson CH, Heilbronn L, Boyd M, Rayner C, Talley NJ, Horowtiz M. Stretton B, et al. Among authors: boyd m. Intern Med J. 2023 Aug;53(8):1311-1320. doi: 10.1111/imj.16126. Epub 2023 Jun 21. Intern Med J. 2023. PMID: 37189293 Review.
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer.
Foote JB, Mattox TE, Keeton AB, Chen X, Smith F, Berry KL, Holmes T, Wang J, Huang CH, Ward AB, Mitra AK, Ramirez-Alcantara V, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Nagaraju GP, Bandi DSR, Maxuitenko YY, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou G, Nurmemmedov E, Babic I, Gaponenko V, Abdelkarim H, Boyd MR, Gorman GS, Manne U, Bae S, El-Rayes BF, Piazza GA. Foote JB, et al. Among authors: boyd mr. bioRxiv [Preprint]. 2024 Oct 7:2023.05.17.541233. doi: 10.1101/2023.05.17.541233. bioRxiv. 2024. Update in: Cancer Res. 2025 Mar 03;85(5):956-972. doi: 10.1158/0008-5472.CAN-24-0323. PMID: 38328254 Free PMC article. Updated. Preprint.
Cancer-associated Fibroblast-specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis.
Hutchenreuther J, Nguyen J, Quesnel K, Vincent KM, Petitjean L, Bourgeois S, Boyd M, Bou-Gharios G, Postovit LM, Leask A. Hutchenreuther J, et al. Among authors: boyd m. Cancer Res Commun. 2024 Feb 27;4(2):556-570. doi: 10.1158/2767-9764.CRC-23-0571. Cancer Res Commun. 2024. PMID: 38363129 Free PMC article.
Dimple piercings: a concerning trend.
Boyd M, Khobaragade B, Mumtaz S. Boyd M, et al. Br Dent J. 2023 Aug;235(3):197. doi: 10.1038/s41415-023-6172-3. Epub 2023 Aug 11. Br Dent J. 2023. PMID: 37563387 No abstract available.
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal Adenocarcinoma.
Reddy Bandi DS, Nagaraju GP, Sarvesh S, Carstens JL, Foote JB, Graff EC, Fang YD, Keeton AB, Chen X, Berry KL, Bae S, Akce M, Gorman G, Yoon KJ, Manne U, Boyd MR, Buchsbaum DJ, Azmi AS, Maxuitenko YY, Piazza GA, El-Rayes BF. Reddy Bandi DS, et al. Among authors: boyd mr. bioRxiv [Preprint]. 2024 Oct 8:2024.10.04.616725. doi: 10.1101/2024.10.04.616725. bioRxiv. 2024. Update in: Mol Cancer. 2025 Mar 13;24(1):76. doi: 10.1186/s12943-025-02288-9. PMID: 39416034 Free PMC article. Updated. Preprint.
Janus-faces of NME-oncoprotein interactions.
Vlatković N, Chang SH, Boyd MT. Vlatković N, et al. Among authors: boyd mt. Naunyn Schmiedebergs Arch Pharmacol. 2015 Feb;388(2):175-87. doi: 10.1007/s00210-014-1062-5. Epub 2014 Nov 1. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 25366701 Review.
The potential of multispectral imaging flow cytometry for environmental monitoring.
Dunker S, Boyd M, Durka W, Erler S, Harpole WS, Henning S, Herzschuh U, Hornick T, Knight T, Lips S, Mäder P, Švara EM, Mozarowski S, Rakosy D, Römermann C, Schmitt-Jansen M, Stoof-Leichsenring K, Stratmann F, Treudler R, Virtanen R, Wendt-Potthoff K, Wilhelm C. Dunker S, et al. Among authors: boyd m. Cytometry A. 2022 Sep;101(9):782-799. doi: 10.1002/cyto.a.24658. Epub 2022 Jun 7. Cytometry A. 2022. PMID: 35670307 Free article. Review.
Implementing Measurement-Based Care in Behavioral Health: A Review.
Lewis CC, Boyd M, Puspitasari A, Navarro E, Howard J, Kassab H, Hoffman M, Scott K, Lyon A, Douglas S, Simon G, Kroenke K. Lewis CC, et al. Among authors: boyd m. JAMA Psychiatry. 2019 Mar 1;76(3):324-335. doi: 10.1001/jamapsychiatry.2018.3329. JAMA Psychiatry. 2019. PMID: 30566197 Free PMC article. Review.
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma.
Bandi DSR, Nagaraju GP, Sarvesh S, Carstens JL, Foote JB, Graff EC, Fang YD, Keeton AB, Chen X, Valiyaveettil J, Berry KL, Bae S, Akce M, Gorman G, Yoon KJ, Manne U, Boyd MR, Buchsbaum DJ, Azmi AS, Maxuitenko YY, Piazza GA, El-Rayes BF. Bandi DSR, et al. Among authors: boyd mr. Mol Cancer. 2025 Mar 13;24(1):76. doi: 10.1186/s12943-025-02288-9. Mol Cancer. 2025. PMID: 40082968 Free PMC article.
1,544 results